Title: Opioid Overdose Reversal Medication Narcan to be Available Over-the-Counter in Drugstores
In a significant move towards combating the opioid crisis, Narcan, a medication that can reverse opioid overdoses within minutes, will soon be available over-the-counter in drugstores. The US Food and Drug Administration (FDA) approved the medication for over-the-counter purchase in March, paving the way for wider accessibility to a drug that has been proven to save lives.
Starting from September 7, Narcan will be stocked in mass drug, pharmacy, and grocery stores, as well as online retailers. Walgreens, one of the largest pharmacy chains in the US, has announced that it will have Narcan available online by September 5, with nationwide availability on September 7. The suggested retail price for two doses will be $44.99.
Narcan, also known as naloxone, is the first opioid overdose reversal medication to be sold without a prescription. This landmark decision comes as a response to the increasing number of opioid overdose deaths in the United States. In 2021, over 80,000 Americans succumbed to opioid overdoses, a dramatic rise from 2020’s figure of 68,630.
Previously, naloxone was available at pharmacies without a prescription, but it was not universally stocked. With the over-the-counter availability of Narcan, consumers will now have the freedom to pick up the medication themselves or retrieve it from the counter with a ticket.
The accessibility of naloxone has steadily increased, rising by nearly 785 percent between 2016 and 2021. However, research suggests that availability must be further expanded to meet the urgent need. Narcan works by blocking the effects of opioids on receptors in the brain, thus restoring normal breathing within two to three minutes of administration.
The new OTC status of Narcan holds the potential to save countless lives. Since most overdose deaths occur in the presence of others, having naloxone readily available can make all the difference. Therefore, it is recommended that everyone, even those who do not consider themselves involved with drug use, carry naloxone and understand how to administer it.
Despite this positive development, challenges remain. Concerns about the pricing of naloxone and its presentation in stores may hinder accessibility for some. Additionally, questions about insurance coverage for over-the-counter naloxone need to be addressed, as this may affect affordability for some individuals.
In a related development, the FDA has also approved another emergency treatment for opioid overdose, called RiVive, for over-the-counter use. The introduction of this alternative medication offers the potential for a cheaper and more accessible option alongside Narcan.
While the distribution of free naloxone through local harm reduction programs will continue in vulnerable communities, the hope is that the increased visibility and availability of Narcan in drugstores will lead to a significant reduction in fatal opioid overdose numbers.
As the nation grapples with the devastating impact of the opioid crisis, expanding access to overdose reversal medications is a crucial step forward in saving lives and addressing a pressing public health issue.
“Social media scholar. Reader. Zombieaholic. Hardcore music maven. Web fanatic. Coffee practitioner. Explorer.”